Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT06302907
Other study ID # M/45- 14.1.2023
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date January 14, 2023
Est. completion date June 30, 2024

Study information

Verified date March 2024
Source Al-Wataniya University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the present study was to evaluate the pain during local anesthetic buccal infiltration for the maxillary canines after adding Sodium Bicarbonate 8.4% during local anesthesia.


Description:

Materials and Methods The present research was approved by the Institutional Review Board of the College of Dentistry at Al Wataniya Private University (M/45- 14.1.2023). 30 healthy patients were recruited, aged between 15-50 years, and divided into two groups (15 males and 15 females). Every patient had to meet the following conditions: - Caries free with no restorations, periapical lesions, or history of trauma at the site of injection. - Willingness to participate in the study and ability to describe and evaluate their pain. - No painkillers, or sedatives taken for at least 24 hours so that pain assessment isn't affected. - No allergy to local anesthetics. - No pregnancy. Each patient received buccal infiltration with the anesthetic solution alone at one upper canine site and local anesthetic with added sodium bicarbonate at the other site. The local anesthetic used was 2% Lidocaine with 1:80.000 Epinephrine produced by New-Stetic S.A.- Colombia. Whereas 8.4% Bicarbonate Sodium was produced by TCE - UK. Injections were performed using 25 mm short needles (Gauge 27) manufactured by C-K Dental - South Korea. Consent for each patient was obtained before the clinical session. Local infiltration was performed using a one-third cartridge (0.6 mL) of the local anesthetic on one side and local anesthetic with added Sodium Bicarbonate on the counterpart side leaving 5 minutes between the injections. Alkalinization of the local anesthetic was performed using the technique described by Saatchi et al13. 0.2 mL of the anesthetic solution was extracted using a tuberculin syringe and then discarded. 0.2 mL sodium bicarbonate was then loaded and added to the cartridge. Afterward, the solution was slowly shaken 20 times and ready to be administered with a cartridge syringe. The 100 mm Visual Analog Scale VAS was utilized as the most commonly used assessment tool to determine the severity of the pain14 where 0 indicates that the patient does not feel pain, while 10 points to unbearable severe pain. The patients must rely on their own experience to confirm the pain's severity.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 30
Est. completion date June 30, 2024
Est. primary completion date September 10, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 15 Years to 50 Years
Eligibility Inclusion Criteria: - Caries free with no restorations, periapical lesions, or history of trauma at the site of injection. - Willingness to participate in the study and ability to describe and evaluate their pain. - No painkillers, or sedatives taken for at least 24 hours so that pain assessment isn't affected. Exclusion Criteria: - allergy to local anesthetics. - pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Buffered Local anaesthesia
A buffered 2% lidocaine with 1:80000 epinephrine and sodium bicarbonate 8.4% was used for one site
Unbuffered Local anaesthesia
an unbuffered 2% lidocaine with 1: 80000 epinephrine for the other site at the same appointment.

Locations

Country Name City State
Syrian Arab Republic Al Wataniya Private University Hama Hama Government

Sponsors (1)

Lead Sponsor Collaborator
Al-Wataniya University

Country where clinical trial is conducted

Syrian Arab Republic, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain on injection - Pain was measured on a visual analogue scale (VAS) starting from 0 which represents (no pain at all) and ending with 10 which represents (the most severe pain) one week
See also
  Status Clinical Trial Phase
Recruiting NCT05432934 - Transversus Abdominis Plane Blocks With and Without Dexamethasone Phase 1/Phase 2
Recruiting NCT06025825 - Comparative Effect of Palatal Injection in Pediatric Patient
Recruiting NCT06171243 - PK of Lidocaine/Tetracaine and PD Derived From a New Topical Formulation for Treatment of Neuropathic Pain.
Recruiting NCT04812639 - Buccal Infiltration Technique Compared to Inferior Alveolar Technique N/A
Not yet recruiting NCT06193460 - Evaluation of the Anti-anaesthetic Effects of Low-Level Laser Therapy on Children's Soft Tissue N/A
Not yet recruiting NCT05233462 - Height Adjusted Versus Standardized Dose of Bupivacaine for Spinal Anesthesia N/A
Terminated NCT04258436 - Serratus Anterior Plane Block for Management of Post Thoracotomy Pain N/A
Completed NCT04821245 - Defining Normal Postoperative Magnetic Resonance Imaging After Total Knee Arthroplasty
Recruiting NCT05864664 - Safety and Efficacy of Wide Awake Local Anesthesia no Tourniquet Technique (WALANT) in Ankle Removal of Implant Surgery N/A